BLLN BillionToOne, Inc.
Company Analysis
Latest News
🔴 BillionToOne is trading 4.02% down in pre-market — no clear company-specific catalyst identified
BillionToOne is trading 4.02% down at $95.50 in pre-market, with no clear company-specific overnight catalyst identified. - It closed at $99.50 on September...
BillionToOne Rated Buy at Canaccord, Citing Exceptional Growth and Profitability
Canaccord Genuity initiated coverage of BillionToOne Inc. (NASDAQ: BLLN) with a Buy rating. The investment firm established a price target of...
🟢 BillionToOne is trading 4.04% up today after Northstar Origin launch
BillionToOne is trading 4.04% up at $96.05 following the September 1, 2026 launch of Northstar Origin. - Northstar Origin is a liquid-biopsy add-on predicting...
🟢 BillionToOne is trading 4.22% up today on Northstar Origin launch
BillionToOne is trading at $94.50, up +4.22%, driven by the Northstar Origin launch. - Launched September 1, 2026, Northstar Origin is a liquid-biopsy add-on...
🟢 BillionToOne is trading 5% up in pre-market with no clear company-specific catalyst
BillionToOne is trading at $100.00 (+5.10%) in pre-market, with no clear company-specific catalyst identified. - The latest reported insider transaction was a...
🔴 BillionToOne is trading 4.62% down today with no clear catalyst
BillionToOne is trading 4.62% down at $95.45 on August 26, 2026; no clear company-specific announcement, filing, analyst action, or other catalyst explains the...
🟢 BillionToOne rises 4.1% — Biotech Sector Gains Amid Broad Market Rally and Positive Sentiment
With Biotech (XBI) up 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, represented by the XBI ETF, is...
🟢 BillionToOne is trading 4.18% up today in an unexplained rebound after August 18 decline
BillionToOne is trading at $95.50, up +4.18%, in what appears to be an unexplained rebound after the August 18 decline. - No new BillionToOne announcement...
🟢 BillionToOne is trading 6.2% up today amid biotech gains on Moderna results
BillionToOne is trading 6.2% up now at $93.46 after recovering from the August 18 decline, primarily as biotech gains 3.73% following favorable investor...
🔴 BillionToOne is trading 4.5% down today as S&P 500 and Nasdaq Composite fall
BillionToOne is trading 4.5% down at $89.71 after opening-session weakness on August 18, 2026, amid broad market weakness. - The S&P 500 is down 0.58% and...
BillionToOne Launches Largest Prenatal Screen, Targeting 50% of Providers
BillionToOne launched its expanded Unity Fetal Risk Screen on August 17, 2026. The 130-gene panel is the largest non-invasive prenatal testing (NIPT) option...
🟢 BillionToOne is trading 4.8% up today after recovering from its August 6 earnings decline
BillionToOne is trading 4.8% up at $97.86 after rebounding from the sharp August 6 earnings-related decline. - Q2 revenue reached $109.4 million, up 64% year...
BillionToOne's second quarter 2026 revenue surged 64% to $109M as the company achieved profitability
BillionToOne reported a 64% year-over-year revenue increase for the second quarter of 2026, reaching $109.4 million and achieving GAAP profitability. Results...